Injective Price Eyes Reversal Above $50 as MACD Signal Aligns With SEC Filing
Injective is attracting renewed market attention as a bullish MACD crossover strengthens technical sentiment while new regulatory progress in the US and Europe supports its real-world asset strategy. Traders are now watching whether growing institutional interest and improving momentum can sustain the tokenโs recovery.
Read from Source ยท tronweekly.com ↗
This content is automatically aggregated. Full credit goes to the original publisher (tronweekly.com).
